Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Stewardship in Community-Acquired Pneumonia With Syndromic Molecular Testing: A Randomized Clinical Trial.
Markussen DL, Serigstad S, Ritz C, Knoop ST, Ebbesen MH, Faurholt-Jepsen D, Heggelund L, van Werkhoven CH, Clark TW, Bjørneklett RO, Kommedal Ø, Ulvestad E, Grewal HMS. Markussen DL, et al. Among authors: clark tw. JAMA Netw Open. 2024 Mar 4;7(3):e240830. doi: 10.1001/jamanetworkopen.2024.0830. JAMA Netw Open. 2024. PMID: 38446481 Free PMC article. Clinical Trial.
Rapid syndromic PCR testing in patients with respiratory tract infections reduces time to results and improves microbial yield.
Serigstad S, Markussen D, Grewal HMS, Ebbesen M, Kommedal Ø, Heggelund L, van Werkhoven CH, Faurholt-Jepsen D, Clark TW, Ritz C, Ulvestad E, Bjørneklett R, Knoop ST; CAPNOR Study Group. Serigstad S, et al. Among authors: clark tw. Sci Rep. 2022 Jan 10;12(1):326. doi: 10.1038/s41598-021-03741-7. Sci Rep. 2022. PMID: 35013351 Free PMC article.
Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR).
Serigstad S, Ritz C, Faurholt-Jepsen D, Markussen D, Ebbesen MH, Kommedal Ø, Bjørneklett RO, Heggelund L, Clark TW, van Werkhoven CH, Knoop ST, Ulvestad E, Grewal HMS; CAPNOR study group. Serigstad S, et al. Among authors: clark tw. Trials. 2022 Aug 1;23(1):622. doi: 10.1186/s13063-022-06467-7. Trials. 2022. PMID: 35915452 Free PMC article. Clinical Trial.
Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial.
Poole S, Tanner AR, Naidu VV, Borca F, Phan H, Saeed K, Grocott MPW, Dushianthan A, Moyses H, Clark TW. Poole S, et al. Among authors: clark tw. J Infect. 2022 Dec;85(6):625-633. doi: 10.1016/j.jinf.2022.09.003. Epub 2022 Sep 9. J Infect. 2022. PMID: 36096312 Clinical Trial.
Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial.
Brendish NJ, Malachira AK, Armstrong L, Houghton R, Aitken S, Nyimbili E, Ewings S, Lillie PJ, Clark TW. Brendish NJ, et al. Among authors: clark tw. Lancet Respir Med. 2017 May;5(5):401-411. doi: 10.1016/S2213-2600(17)30120-0. Epub 2017 Apr 6. Lancet Respir Med. 2017. PMID: 28392237 Free PMC article. Clinical Trial.
FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department.
Mansbridge CT, Tanner AR, Beard KR, Borca F, Phan HTT, Brendish NJ, Poole S, Hill C, Kiuber M, Crouch R, Waddington D, Clark TW. Mansbridge CT, et al. Among authors: clark tw. Infect Control Hosp Epidemiol. 2022 Aug;43(8):979-986. doi: 10.1017/ice.2021.531. Epub 2022 Jan 31. Infect Control Hosp Epidemiol. 2022. PMID: 35094739 Free PMC article.
261 results